A Prospective, Randomized, Multicenter Trial of Pregabalin and Celecoxib for Lumbar Spinal Stenosis

A Prospective, Randomized, Multicenter Trial of Pregabalin and Celecoxib for Lumbar Spinal Stenosis - A Prospective, Randomized, Multicenter Trial of Pregabalin and Celecoxib for Lumbar Spinal Stenosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007419

Enrollment

Registered

2012-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spinal Stenosis

Interventions

Celecoxib Pregabalin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: LSS patients who represent 7 points and over in LSS diagnosis tool LSS patients who represents 6 points and under in LSS diagnosis tool but diagnosed by MRI Conform to the combined drug standard NRS 4 points and over At the age 50 to 89 Using NSAIDs except Celecoxib over two weeks

Exclusion criteria

Exclusion criteria: Arteriosclerosis obliterans Diabetic neuropathy Anterior tibial muscle MMT 3 and below Ineffectiveness of epidural block over 3 times in a month Vesicorectal disturbance Heart failure Herniated disc disase

Design outcomes

Primary

Measure	Time frame
The recovery of pain and ADL four weeks after the administration	—

Secondary

Measure	Time frame
The recovory of NRS, ODI, SF-36 score four weeks after the administration	—

Countries

Japan

Contacts

Public ContactKoichiro Maeno

Kobe university Graduate School of Medicine Department of Orthopedic Surgery

takada-t@hokuto-hp.or.jp078-382-5985

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026